Activators identified for the treatment of patients with diabetes and insulin resistance
La Vanguardia, La Razón, Correo Farmacéutico, Health Canal, among other national and international media, have published an article about the research led by Antonio Zorzano, from IRB Barcelona, and Fernando Albericio, from the University of Barcelona. This study reveals activators of mitochondrial protein Mitofusin 2 that may be valuable in the treatment of type 2 diabetes.
Link to La Vanguardia
Link to Correo Farmacéutico
Link to Health Canal
Related content
News
The team headed by ICREA researcher, Lluís Ribas, has published a study in Cell Report describing a functional network that coordinates protein synthesis and DNA replication in animal mitochondria.
These findings contribute to our understanding of the mechanisms involved in mitochondrial dysregulation associated with diseases such as MELAS and MERRF and may help to identify new therapeutic approaches.
Oriol Gallego, IRB Barcelona Alumni is currently a Group Leader at the Pompeu Fabra University (Barcelona).
Oriol talks about his current research projects, his relationship with IRB Barcelona and about how it is to create his own group.
Ana Janic received her PhD in 2011 after completing her her doctoral studies in Cayetano González’s Cell Division Laboratory.
The jury for the prize acknowledged the outstanding quality of Ana Janic’s contributions to science, and her seniority along her career.
